2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What Major Innovations Are Driving the Accelerated Growth of the Cannabis Pharmaceuticals Market?
An increase in epilepsy occurrences is anticipated to propel the cannabis pharmaceuticals market in the future. Epilepsy is a neurological disorder marked by frequent, unprovoked seizures caused by irregular electrical activity in the brain. This surge in epilepsy cases might be due to improved diagnostics, heightened awareness, better reporting, along with potential environmental, lifestyle and genetic factors. Cannabis pharmaceuticals have demonstrated capabilities in controlling epilepsy, with cannabinoids like CBD in reducing the intensity and number of seizures in patients who are unresponsive to conventional anti-epileptic drugs. For example, as of April 2022, the European Brain Council, a Belgian non-profit organization, reports that more than 600 neurological diseases and close to 300 psychiatric conditions afflict millions worldwide, which includes 65 million epilepsy patients. Also, in July 2024, the Alzheimer Society of Canada, a Canadian health charity, suggests that over 771,939 Canadians are likely to be diagnosed with dementia by January 1, 2025, and almost one million are expected suffer from it by 2030. As a consequence, the increase in epilepsy cases is fueling the expansion of the cannabis pharmaceuticals market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20723&type=smp
#What is the Projected CAGR for the Cannabis Pharmaceuticals Market Size from 2025 to 2034?
The market size for cannabis pharmaceuticals has been expanding drastically over the past few years. It is predicted to increase from $6.03 billion in 2024 to $9.45 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 56.66%. Factors contributing to the growth during the historic period include the expanding legalization of medicinal marijuana, increased understanding of the therapeutic benefits of cannabinoids, growth in the occurrence of chronic and neurological health issues, accommodating regulatory environments, growing investments in the pharmaceutical sector, and changing attitudes of the public toward the use of cannabis in healthcare.
In the upcoming years, the cannabis pharmaceuticals market size is projected to experience stellar growth, anticipated to reach $56.37 billion by 2029, with a compound annual growth rate (CAGR) of 56.29%. This growth within the forecast period can be credited to several factors such as the rise in regulatory approvals, mounting recognition of the medical advantages of cannabis, wider application in pain and neurological disorder treatment, an upsurge in chronic illnesses, innovative drug delivery systems, and the establishment of supportive reimbursement policies. Influential trends during the forecast period are expected to be advancements in cannabinoid extraction technologies, the development of targeted drug delivery systems, the use of synthetic cannabinoid formulations, enhancement of clinical trial methodologies, and employment of artificial intelligence for drug discovery.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20723
What Are the Most Significant Market Trends Transforming theCannabis Pharmaceuticals Market?
Prominent corporations in the cannabis pharmaceuticals market are concentrating on the creation of novel, innovative products, notably advanced medical cannabis formulations. These are intended to treat a variety of health conditions and improve the overall wellbeing of patients. Advanced medical cannabis formulations are cannabis-based products that are specifically created for therapeutic purposes. They contain accurate doses of cannabinoids such as THC and CBD. For example, in April 2024, Switzerland’s pharmaceutical firm, Canexis Pharma AG, was granted manufacturing and narcotics licenses by Swissmedic for creating cannabis pharmaceuticals. These endorsements give the company the approval to manufacture topnotch medicinal active ingredients from CBD and THC. Canexis is thus positioned to satisfy the escalating demand for medical cannabis in Switzerland and across the globe. The acquisition of these licenses demonstrates the company’s adherence to rigorous regulatory guidelines, thereby boosting its credibility and enhancement towards the fast-paced evolution of the medical cannabis market.
What Are the Top Market Players Propelling the Growth of theCannabis Pharmaceuticals Industry?
Major companies operating in the cannabis pharmaceuticals market are Curaleaf Holdings Inc., Aphria Inc., Green Thumb Industries Inc., Trulieve Cannabis Corp., Tilray Inc., Cresco Labs Inc., Columbia Care Inc., Acreage Holdings Inc., Canopy Growth Corporation, Aurora Cannabis Inc., MedMen Enterprises Inc., OrganiGram Holdings Inc., Cronos Group, Enveric Biosciences Inc., Auxly Cannabis Group Inc., Valens Company Inc., Charlotte’s Web Holdings Inc., Medical Marijuana Inc., Aleafia Health Inc., Supreme Cannabis Company Inc., Avicanna Inc., Emerald Health Therapeutics Inc.
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/cannabis-pharmaceuticals-global-market-report
Which Primary Segments of the Cannabis Pharmaceuticals Market Are Driving Growth and Industry Transformations?
The cannabis pharmaceuticals market covered in this report is segmented –
1) By Product Type: Cannabinoid-Based Pharmaceuticals, Cannabis Extracts, Synthetic Cannabinoids
2) By Formulation Type: Capsules And Tablets, Oils And Tinctures, Topical Solutions
3) By Therapeutic Application: Cancer, Neurological Disorders, Pain Management
4) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies
5) By End-User: Hospitals And Clinics, Rehabilitation Centers, Research Organizations
Subsegments:
1) By Cannabinoid-Based Pharmaceuticals: THC-Based Pharmaceuticals, CBD-Based Pharmaceuticals, Combination of THC and CBD Pharmaceuticals, Other Cannabinoid-Based Formulations
2) By Cannabis Extracts: Full-Spectrum Cannabis Extracts, Broad-Spectrum Cannabis Extracts, Isolate Cannabis Extracts (CBD Isolate)
3) By Synthetic Cannabinoids: Synthetic THC Analogues, Synthetic CBD Analogues, Synthetic Cannabinoid Receptor Agonists, Designer Synthetic Cannabinoids
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=20723&type=smp
Which Regions Are Key Players in the Growth of the #What Major Innovations Are Driving the Accelerated Growth of the Cannabis Pharmaceuticals Market?# Market?
North America was the largest region in the cannabis pharmaceuticals market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cannabis pharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Reports Similar to the Global Cannabis Pharmaceuticals Market 2025, By The Business Research Company:
Cannabis Products Global Market Report 2025
https://thebusinessresearchcompany.com/report/cannabis-products-global-market-report
Cannabis Testing Global Market Report 2025
https://thebusinessresearchcompany.com/report/cannabis-testing-global-market-report
Cannabis Cultivation Global Global Market Report 2025
https://thebusinessresearchcompany.com/report/cannabis-cultivation-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: